SCHEMBL28089696

SCHEMBL28089696

C/C=C/C.CCOC(=O)CCCCC(=O)OCC

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.61
ALDH1A1 P00352 3/20 0.55
TSHR P16473 2/20 0.55
ALOX15 P16050 2/20 0.55
TDP1 Q9NUW8 2/20 0.55
CYP3A4 P08684 1/20 0.55
HSD17B10 Q99714 1/20 0.55
NR1I2 O75469 1/20 0.53
PGR P06401 1/20 0.53
ADORA3 P0DMS8 1/20 0.53
PTGS2 P35354 1/20 0.53
PDE4D Q08499 1/20 0.53
GAA P10253 2/20 0.50
MGAM O43451 1/20 0.50
SI P14410 1/20 0.50
MGAM2 Q2M2H8 1/20 0.50
DGKA P23743 1/20 0.50
CYP4F2 P78329 1/20 0.47
CYP4A11 Q02928 1/20 0.47
TRPA1 O75762 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8570508 0.90 CYP1A2 (0.73) CYP1A2ALDH1A1TSHRALOX15TDP1
SCHEMBL50610 0.90 CYP1A2 (0.73) CYP1A2ALDH1A1TSHRALOX15TDP1
Diethyl Octadecanedioate SCHEMBL496152 0.87 CYP1A2 (0.70) CYP1A2ALDH1A1TSHRALOX15TDP1
SCHEMBL19066941 0.87 CYP1A2 (0.70) CYP1A2ALDH1A1TSHRALOX15TDP1
SCHEMBL494100 0.87 CYP1A2 (0.70) CYP1A2ALDH1A1TSHRALOX15TDP1
SCHEMBL6055406 0.87 CYP1A2 (0.70) CYP1A2ALDH1A1TSHRALOX15TDP1
SCHEMBL1483107 0.87 CYP1A2 (0.70) CYP1A2ALDH1A1TSHRALOX15TDP1
SCHEMBL33870 0.87 CYP1A2 (0.70) CYP1A2ALDH1A1TSHRALOX15TDP1
SCHEMBL495925 0.87 CYP1A2 (0.70) CYP1A2ALDH1A1TSHRALOX15TDP1
SCHEMBL440349 0.87 CYP1A2 (0.70) CYP1A2ALDH1A1TSHRALOX15TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110267948-A Modulators of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and methods of making the modulators 弗特克斯药品有限公司 2019-09-20 CN disclosed
CN-109843856-A KRAS G12C inhibitor 米拉蒂治疗股份有限公司 2019-06-04 CN disclosed
CN-101652066-B Hydroxymethyl ether hydroisoindoline tachykinin receptor antagonists 默沙东公司 2016-08-17 CN disclosed